Rare interstitial lung diseases: a narrative review
- PMID: 39444900
- PMCID: PMC11494586
- DOI: 10.21037/jtd-24-450
Rare interstitial lung diseases: a narrative review
Abstract
Background and objective: Interstitial lung diseases (ILDs) encompass over 200 entities. Among them, fibrosing lung diseases, have recently generated special interest due to the emerging therapies for their management. However, it is important to deepen our knowledge of other less prevalent ILD, since many of them are associated with a poor prognosis. This narrative review aims to provide a practical and up-to-date description of some poorly recognized ILD. It covers rare idiopathic interstitial pneumonias and their histologic patterns, genetic disorders with interstitial lung involvement (Hermansky-Pudlak syndrome), and ILD associated with benign proliferation of pulmonary lymphoid tissue, namely follicular bronchiolitis and granulomatous-lymphocytic interstitial lung disease.
Methods: Electronic searches of PubMed and Google Scholar using specific keywords were conducted. Articles underwent screening for relevance, covering review articles, meta-analyses, systematic reviews, case series, prospective studies, society guidelines, editorials in peer-reviewed journals; scientific books on the subject. The data included was limited to English and Spanish publications.
Key content and findings: Despite the low prevalence of these diseases, the increased recognition of radiological patterns, pathological features, and diagnostic procedures, have permitted their better characterization. This review highlights epidemiology, clinical presentation, diagnosis, natural history, and treatment.
Conclusions: Lesser-studied ILD represent a diagnostic and therapeutic challenge and can be frequently misdiagnosed. Also, due to the lack of randomized controlled trials, there are no well-established therapeutic options. Further studies or registries are needed to improve accurate diagnosis and management.
Keywords: Hermansky-Pudlak syndrome (HPS); Rare idiopathic interstitial pneumonias; acute fibrinous organizing pneumonia (AFOP); granulomatous-lymphocytic interstitial lung disease (GLILD).
2024 AME Publishing Company. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-450/coif). The authors have no conflicts of interest to declare.
Figures







Similar articles
-
Spectrum of fibrosing diffuse parenchymal lung disease.Mt Sinai J Med. 2009 Feb;76(1):2-23. doi: 10.1002/msj.20087. Mt Sinai J Med. 2009. PMID: 19170214 Review.
-
Role of High-Resolution CT Thorax in Diagnosing Interstitial Lung Disease and Its Association With Smoking and Connective Tissue Disorder.Cureus. 2022 Nov 4;14(11):e31107. doi: 10.7759/cureus.31107. eCollection 2022 Nov. Cureus. 2022. PMID: 36475156 Free PMC article.
-
Rare idiopathic interstitial pneumonias: LIP and PPFE and rare histologic patterns of interstitial pneumonias: AFOP and BPIP.Respirology. 2016 May;21(4):600-14. doi: 10.1111/resp.12693. Epub 2015 Dec 2. Respirology. 2016. PMID: 26627191 Review.
-
Relationship between idiopathic interstitial pneumonias (IIPs) and connective tissue disease-related interstitial lung disease (CTD-ILD): A narrative review.Respir Investig. 2024 May;62(3):465-480. doi: 10.1016/j.resinv.2024.03.006. Epub 2024 Apr 1. Respir Investig. 2024. PMID: 38564878 Review.
-
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature.Autoimmun Rev. 2016 Jan;15(1):61-70. doi: 10.1016/j.autrev.2015.09.003. Epub 2015 Sep 16. Autoimmun Rev. 2016. PMID: 26384526 Review.
Cited by
-
Harnessing organoid technology to model autoimmune pathways in rheumatological and inflammatory disorders.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 15. doi: 10.1007/s00210-025-04387-2. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40663155 Review.
References
-
- American Thoracic Society. European Respiratory Society . American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304. Erratum in: Am J Respir Crit Care Med 2002;166:426. - PubMed
-
- Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-48. 10.1164/rccm.201308-1483ST - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources